Skip to main content
. 2021 Mar 17;2021(3):CD013732. doi: 10.1002/14651858.CD013732.pub2

Comparison 1. Any opioid (e.g. morphine, diamorphine, fentanyl, alfentanil, sufentanil, pethidine, meperidine, codeine) compared to control (placebo or no intervention), with or without other non‐pharmacological measures.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Pain (PIPP) 5   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1.1 < 12 hours after infusion 2 50 Mean Difference (IV, Fixed, 95% CI) ‐5.74 [‐6.88, ‐4.59]
1.1.2 ≥ 12 and < 48 hours after infusion 3 963 Mean Difference (IV, Fixed, 95% CI) ‐0.98 [‐1.35, ‐0.61]
1.1.3 Multiple time points (e.g. during endotracheal suctioning) 1 150 Mean Difference (IV, Fixed, 95% CI) 0.10 [‐0.73, 0.93]
1.2 Pain (NFCS) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.2.1 < 12 hours after infusion 1 22 Mean Difference (IV, Fixed, 95% CI) 0.19 [‐1.15, 1.53]
1.3 Pain (NIPS) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.3.1 Multiple time points (e.g. during endotracheal suctioning) 1 150 Mean Difference (IV, Fixed, 95% CI) ‐0.19 [‐0.72, 0.34]
1.4 Pain (COMFORTneo) 2   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.4.1 ≥ 12 and < 48 hours after infusion 2 65 Mean Difference (IV, Fixed, 95% CI) ‐3.33 [‐4.98, ‐1.68]
1.5 Duration of ventilation (days) 7   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.5.1 All studies 7 1259 Mean Difference (IV, Fixed, 95% CI) 0.23 [‐0.38, 0.83]
1.5.2 With no dose adjustments or open‐label boluses 3 111 Mean Difference (IV, Fixed, 95% CI) 0.03 [‐0.62, 0.67]
1.5.3 Very preterm infants only 3 1003 Mean Difference (IV, Fixed, 95% CI) 0.17 [‐0.47, 0.80]
1.6 Neonatal mortality 5   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.6.1 All studies 5 1189 Risk Ratio (M‐H, Fixed, 95% CI) 1.12 [0.80, 1.55]
1.6.2 With no dose adjustments or open‐label boluses 1 41 Risk Ratio (M‐H, Fixed, 95% CI) 1.27 [0.32, 4.98]
1.6.3 Very preterm infants only 2 943 Risk Ratio (M‐H, Fixed, 95% CI) 1.18 [0.82, 1.68]
1.7 Mortality to discharge 4   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.7.1 All studies 4 178 Risk Ratio (M‐H, Fixed, 95% CI) 0.99 [0.52, 1.88]
1.7.2 With no dose adjustments or open‐label boluses 2 67 Risk Ratio (M‐H, Fixed, 95% CI) 1.43 [0.47, 4.32]
1.8 Neurodevelopmental outcome at 18 to 24 months (moderate to severe disability) 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.8.1 All studies 1 78 Risk Ratio (M‐H, Fixed, 95% CI) 2.00 [0.39, 10.29]
1.8.2 Very preterm infants only 1 78 Risk Ratio (M‐H, Fixed, 95% CI) 2.00 [0.39, 10.29]
1.9 Neurodevelopmental outcome at 5 to 6 years (disability) 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.9.1 All studies 1 95 Risk Ratio (M‐H, Fixed, 95% CI) 1.60 [0.56, 4.56]
1.10 Weight gain at discharge (g/kg per day) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.10.1 All studies 1 45 Mean Difference (IV, Fixed, 95% CI) ‐0.18 [‐0.64, 0.28]
1.10.2 Very preterm infants only 1 45 Mean Difference (IV, Fixed, 95% CI) ‐0.18 [‐0.64, 0.28]
1.11 Days to reach full enteral feeding 3   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.11.1 All studies 3 974 Mean Difference (IV, Fixed, 95% CI) 1.68 [0.12, 3.25]
1.11.2 With no dose adjustments or open‐label boluses 1 31 Mean Difference (IV, Fixed, 95% CI) 0.00 [‐3.52, 3.52]
1.11.3 Very preterm infants only 2 943 Mean Difference (IV, Fixed, 95% CI) 2.10 [0.35, 3.85]
1.12 Length of stay in hospital (days) 3   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.12.1 All studies 3 131 Mean Difference (IV, Fixed, 95% CI) 1.85 [‐6.88, 10.57]
1.12.2 With no dose adjustments or open‐label boluses 1 31 Mean Difference (IV, Fixed, 95% CI) ‐2.00 [‐26.74, 22.74]
1.12.3 Very preterm infants only 1 45 Mean Difference (IV, Fixed, 95% CI) ‐1.40 [‐18.48, 15.68]
1.13 Oxygen at 28 days of life (BPD any grade) 4   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.13.1 All studies 4 262 Risk Ratio (M‐H, Fixed, 95% CI) 1.19 [0.73, 1.92]
1.13.2 With no dose adjustments or open‐label boluses 2 57 Risk Ratio (M‐H, Fixed, 95% CI) 1.10 [0.36, 3.37]
1.14 Oxygen at 36 weeks' postmenstrual age (BPD moderate or severe) 4   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.14.1 All studies 4 964 Risk Ratio (M‐H, Fixed, 95% CI) 0.99 [0.80, 1.23]
1.14.2 With no dose adjustments or open‐label boluses 2 40 Risk Ratio (M‐H, Fixed, 95% CI) 0.18 [0.03, 0.92]
1.14.3 Very preterm infants only 2 924 Risk Ratio (M‐H, Fixed, 95% CI) 1.05 [0.85, 1.31]
1.15 Necrotising enterocolitis 6   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.15.1 All studies 5 1278 Risk Ratio (M‐H, Fixed, 95% CI) 1.03 [0.61, 1.76]
1.15.2 With no dose adjustments or open‐label boluses 1 46 Risk Ratio (M‐H, Fixed, 95% CI) 1.09 [0.07, 16.41]
1.15.3 Very preterm infants only 2 1029 Risk Ratio (M‐H, Fixed, 95% CI) 1.09 [0.56, 2.10]
1.16 Any intraventricular haemorrhage (IVH) 8   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.16.1 All studies 8 515 Risk Ratio (M‐H, Fixed, 95% CI) 0.84 [0.65, 1.09]
1.16.2 With no dose adjustments or open‐label boluses 4 133 Risk Ratio (M‐H, Fixed, 95% CI) 0.87 [0.51, 1.49]
1.16.3 Very preterm infants only 2 176 Risk Ratio (M‐H, Fixed, 95% CI) 0.84 [0.53, 1.33]
1.17 Severe intraventricular haemorrhage (Papile grade 3/4) 6   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.17.1 All studies 6 1299 Risk Ratio (M‐H, Fixed, 95% CI) 0.98 [0.71, 1.34]
1.17.2 With no dose adjustments or open‐label boluses 1 20 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.02, 7.32]
1.17.3 Very preterm infants only 3 1074 Risk Ratio (M‐H, Fixed, 95% CI) 1.09 [0.78, 1.52]
1.18 Periventricular leukomalacia (PVL) 7   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.18.1 All studies 7 1345 Risk Ratio (M‐H, Fixed, 95% CI) 0.83 [0.57, 1.21]
1.18.2 With no dose adjustments or open‐label boluses 2 66 Risk Ratio (M‐H, Fixed, 95% CI) 1.07 [0.48, 2.42]
1.18.3 Very preterm infants only 3 1074 Risk Ratio (M‐H, Fixed, 95% CI) 0.75 [0.47, 1.19]
1.19 Hypotension requiring medical treatment 3   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.19.1 All studies 3 1083 Risk Ratio (M‐H, Fixed, 95% CI) 1.39 [1.13, 1.72]
1.19.2 With no dose adjustments or open‐label boluses 1 41 Risk Ratio (M‐H, Fixed, 95% CI) 1.27 [0.32, 4.98]
1.19.3 Very preterm infants only 1 898 Risk Ratio (M‐H, Fixed, 95% CI) 1.62 [1.25, 2.11]